The legacy success of sildenafil has undeniably transformed the pharmaceutical landscape. However, putting money in companies heavily dependent on biosimilars and the waning patent exclusivity surrounding https://guidemysocial.com/story6880367/the-blue-pill-and-drugmakers-a-uncertain-investment